Metoclopramide Hydrochloride Accord Healthcare Ireland (Metoclopramide Hydrochloride)

The drug blocks dopamine D2 receptors in the brain’s chemoreceptor trigger zone, reducing the stimulus for vomiting. It also increases acetylcholine activity in the gut, promoting motility and accelerating gastric emptying, which together provide its anti‑emetic and pro‑kinetic actions.

The appropriate dose of Metoclopramide Hydrochloride is determined by the prescribing clinician based on the patient’s condition, age, renal function and other factors. Healthcare professionals set the exact regimen and duration for each individual case.

Safety data for Metoclopramide during pregnancy are limited, and the drug should only be used when the potential benefit outweighs any risk to the fetus. Caution is also advised during breastfeeding, as the medication can pass into breast milk; a healthcare provider should evaluate the need.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many anti‑emetics by combining dopamine antagonism with pro‑kinetic activity, making it useful for both nausea control and gastric motility disorders. Other agents, such as ondansetron, act primarily on serotonin receptors and lack the pro‑kinetic effect.

Metoclopramide Hydrochloride tablets should be stored at ambient temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and avoid exposure to extreme heat or humidity.

The medication is taken orally, usually with a glass of water. It can be administered with or without food, depending on the prescriber’s instructions. Patients should follow the dosing schedule provided by their healthcare professional.

Serious adverse effects include tardive dyskinesia, a potentially irreversible movement disorder, neuroleptic malignant syndrome, and severe allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

Metoclopramide is contraindicated in individuals with known hypersensitivity to the drug, in patients with pheochromocytoma, and should be used with extreme caution in those with Parkinson’s disease, seizure disorders, or severe depression. A prescriber must evaluate each patient’s medical history before initiating therapy.